Clinical trial
Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage…
NCT00003654 · UNICANCER, Other · Terminated
Key facts
| NCT number | NCT00003654 |
|---|---|
| Title | Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer |
| Official title | Diagnostic Study of Patent Blue V Dye to Identify Sentinel Lymph Nodes in Patients With Stage I or IIA Breast Cancer |
| Lead sponsor | UNICANCER, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | patent blue V dye, lymphangiography, radionuclide imaging, sentinel lymph node biopsy, technetium Tc 99m sulfur colloid |
| Enrollment | 200 |
| Start date | Sep 1, 1997 |
| Primary completion | Jan 1, 2000 |
| Completion | Jan 1, 2000 |
| First posted | Aug 26, 2004 |
| Last update posted | Feb 21, 2021 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: